Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2009
11/19/2009US20090286860 Method of using adenoviral vectors to induce an immune response
11/19/2009US20090286737 Erbb interface peptidomimetics and methods of use thereof
11/19/2009US20090286734 Pharmaceutical Use of Alpha Antigen or Alpha Antigen Gene
11/19/2009US20090286316 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
11/19/2009US20090286312 Methods and Compositions for Treating Allergic Diseases
11/19/2009US20090286265 Cripto Blocking Antibodies And Uses Thereof
11/19/2009US20090285901 Polyamino acid for use as adjuvant
11/19/2009US20090285879 Malaria prime/boost vaccines
11/19/2009US20090285863 Coating Composition Comprising Starch
11/19/2009US20090285861 Tumor cell-based cancer immunotherapeutic compositions and methods
11/19/2009US20090285860 Cancer immunotherapy
11/19/2009US20090285859 Allergenic proteins of natural rubber latex, their production and use in assays
11/19/2009US20090285858 Prevention of allergy in children
11/19/2009US20090285857 Recombinant chimeric antigens for diagnosis and prevention of scrub typhus
11/19/2009US20090285856 Helicobacter species and cultivation thereof
11/19/2009US20090285855 Recombinant vaccine against japanese encephalitis virus (jev) infection and a method thereof
11/19/2009US20090285854 Frozen stockpiling of influenza vaccines
11/19/2009US20090285853 Nucleic Acids Encoding Respiratory Syncytial Virus Subgroup B strain 9320
11/19/2009US20090285852 Expression System Incorporating a Capsid Promotor Sequence as an Enhancer of a Cytomegalovirus Promotor
11/19/2009US20090285851 Vaccine comprising monocyte or immature myeloid cells (imc) which were loaded with the ligand of natural killer t cell and antigen
11/19/2009US20090285849 Thiosemicarbazones as anti-virals and immunopotentiators
11/19/2009US20090285848 Methods and compositions for immunizing against pseudomonas infection
11/19/2009US20090285847 Compositions And Methods For Immunodominant Antigens of Mycobacterium Tuberculosis
11/19/2009US20090285846 Mutants of cholesterol-dependent cytolysins and uses thereof
11/19/2009US20090285845 Domains And Epitopes Of Meningococcal Protein NMB1870
11/19/2009US20090285844 Non-toxic mutants of pathogenic gram-negative bacteria
11/19/2009US20090285843 Epitope sequences
11/19/2009US20090285842 Immune privileged and modulatory progenitor cells
11/19/2009US20090285841 Antitumor combinations containing a vegf-inhibiting agent and 5fu or a derivative thereof
11/19/2009US20090285840 Methods for treating pathological neovascularization
11/19/2009US20090285839 Antigen uptake receptor for candida albicans on dendritic cells
11/19/2009US20090285838 Use of soluble cd164 in inflammation and autoimmune disorders
11/19/2009US20090285837 Her2 antibody composition
11/19/2009US20090285836 Use of salinosporamide a to inhibit metastasis
11/19/2009US20090285835 Antibodies which bind human CXCR3
11/19/2009US20090285834 Novel memory ctl induction potentiator
11/19/2009US20090285833 Clostridium botulinum c3 exotransferase compositions and methods for treating tumour spreading
11/19/2009US20090285832 Methods for treating sunitinib-resistant carcinoma and related biomarkers
11/19/2009US20090285831 Immunointeractive molecules
11/19/2009US20090285830 Antibodies to lymphotoxin-alpha
11/19/2009US20090285829 Medicinal Agent and Method for Curing Prostate Diseases
11/19/2009US20090285828 Anti-PECAM Therapy for Metastasis Suppression
11/19/2009US20090285827 Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8 associated disorders
11/19/2009US20090285826 Combination drugs comprising vegf inhibitor and serine proteases/thrombolytic compounds for treating neovascular disorders
11/19/2009US20090285825 Novel snake toxin
11/19/2009US20090285824 immunoglobulins; humanizing; chimera; fragments; complementary determining regions; breast cancer
11/19/2009US20090285823 Glycopeptides derived from pancreatic structures, antibodies and applications thereof in diagnostics and therapeutics
11/19/2009US20090285822 Prevention and treatment of amyloidogenic disease
11/19/2009US20090285821 Campylobacter Pilus Protein, Compositions and Methods
11/19/2009US20090285820 Methods of Treating Degenerative Disorders With Rac 1B Inhibitor
11/19/2009US20090285819 Methods and compositions for treating influenza
11/19/2009US20090285818 Cripto Blocking Antibodies and Uses Thereof
11/19/2009US20090285817 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
11/19/2009US20090285816 Albumin Fusion Proteins
11/19/2009US20090285815 Immunoconjugates comprising cd4 and immunoglobin molecules for the treatment of hiv infection
11/19/2009US20090285814 CD 40 Binding Molecules and CTL Pepetides for Treating Tumors
11/19/2009US20090285813 Antibodies and methods for making and using them
11/19/2009US20090285812 human P-selectin glycoprotein ligand 1 (PSGL-1) monoclonal antibodies which block both selectin and chemokine binding to PSGL-1 expressed on leukocytes, lymphocytes and endothelial cells; inflammation such as inflammatory bowel disease
11/19/2009US20090285811 Anti-inflammatory and immunosuppressive glucocorticoid steroids
11/19/2009US20090285810 Humanized anti-tgf-beta antibodies
11/19/2009US20090285809 Prevention and treatment of amyloidogenic diseases
11/19/2009US20090285808 Anti-cd19 antibodies and uses in oncology
11/19/2009US20090285807 Anti-Met Monoclonal Antibody, Fragments and Vectors Thereof, for the Treatment of Tumors and Corresponding Products
11/19/2009US20090285806 Methods and compositions for improving recombinant protein production
11/19/2009US20090285805 Binding molecules
11/19/2009US20090285804 Anti-ADDLs antibodies and uses thereof
11/19/2009US20090285803 ANTI-PirB ANTIBODIES
11/19/2009US20090285802 Highly concentrated stabilized igm solution
11/19/2009US20090285801 Calcium-Sensing Receptor 2 (CaR2) and Methods for Using
11/19/2009US20090285800 Aberrant expression of CKS1 and CKS2 and uses thereof
11/19/2009US20090285799 Antibody Antagonists of Interleukin-13 Receptor Alpha1
11/19/2009US20090285798 Cd4 mimic peptides and their uses
11/19/2009US20090285797 Use of inhibitors of cyp2a6 for regulating nicotine metabolism
11/19/2009US20090285796 Mutant jak3 kinase in human leukemia
11/19/2009US20090285795 Method for the Production of a Monoclonal Antibody to CD20 for the Treatment of B-Cell Lymphoma
11/19/2009US20090285781 Medicament and a method of treating a pathological syndrome
11/19/2009US20090285779 Induction of apoptosis in toll-like receptor expressing tumor cells
11/19/2009US20090285777 Uses of Mammalian Cytokine; Related Reagents
11/19/2009US20090285776 Irreversibly-inactivated pepsinogen fragments for modulating immune function
11/19/2009US20090285772 Quinoline derivatives for modulating dna methylation
11/19/2009US20090285771 Methods and compositions for needleless delivery of macromolecules
11/19/2009US20090285762 Imaging methods and compositions comprising fluorescent dyes associated with viral components for nerve imaging
11/19/2009US20090285757 Methods of targeting cells for diagnosis and therapy
11/19/2009US20090285752 Immunotherapy of b cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins
11/19/2009US20090285751 Cancerous disease modifying antibodies
11/19/2009DE102008029669A1 Neue Therapeutika für die Hepatitis-Therapie New therapeutics for the treatment of hepatitis
11/19/2009CA2760493A1 Staphylococcus aureus-specific antibody preparations
11/19/2009CA2760041A1 Methods and compositions for the treatment of cancer
11/19/2009CA2724418A1 Long term disease modification using immunostimulatory oligonucleotides
11/19/2009CA2724415A1 Anti-psgl-1 antibodies and methods of identification and use
11/19/2009CA2724409A1 Anti-cxcr4 antibodies
11/19/2009CA2724279A1 Anti-il-6/il-6r antibodies and methods of use thereof
11/19/2009CA2724246A1 Anticancer combination therapy including triciribine
11/19/2009CA2724208A1 Amino acid sequences directed against cxcr4 and other gpcrs and compounds comprising the same
11/19/2009CA2724173A1 Methods of detecting cells with a disrupted cell membrane, cells infected with a pathogen, dying cells or dead cells
11/19/2009CA2724071A1 Plasmacytoid dendritic cell line used in active or adoptive cell therapy
11/19/2009CA2723822A1 Set of antiangiogenic molecules and use thereof
11/19/2009CA2723617A1 Combinations vegf(r) inhibitors and hepatocyte growth factor (c-met) inhibitors for the treatment of cancer
11/19/2009CA2723614A1 Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists
11/19/2009CA2723430A1 Anti-pirb antibodies
1 ... 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 ... 1823